Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SDK to Enter Purification Resin Market through Strategic Investment

Published: Monday, December 10, 2012
Last Updated: Monday, December 10, 2012
Bookmark and Share
SDK expects to achieve good synergistic effect in terms of both technology and product mix.

Showa Denko K.K. (SDK) has signed a strategic partnership agreement with BIA Separations (BIASep), of Austria.

The partnership includes SDK’s investment in BIASep as well as joint marketing and R&D.

With the partnership, SDK will be ready to expand its business to a market of purification resins used for manufacturing biopharmaceuticals and for industrial applications.

SDK is conducting a separation/refining business, developing, manufacturing, and selling various products pertaining to high-performance liquid chromatography (HPLC).

SDK has been providing a wide variety of analytical HPLC columns with the brand name of “Shodex™” for more than 40 years.

The Shodex™ columns are delivered to wide-ranging customers in the world, including public institutions and R&D/quality control sectors of private enterprises, through the Showa Denko Group’s global sales network.

This time, SDK decided to enter the purification resin market through the strategic partnership with BIASep, expecting to achieve good synergistic effect in terms of both technology and product mix.

The market is expected to grow rapidly with the expansion of the biopharmaceutical industry. SDK will fully utilize the technologies it has amassed through the Shodex™ business to enhance the synergies.

Purification resins are used for refining desired components/chemicals from culture/reaction solutions for biopharmaceutical and industrial manufacturing processes.

SDK’s protein analysis technology and know-how acquired through the Shodex™ business will be fully utilized, as protein purification plays a key role in the purifying process for biopharmaceuticals.

Efficiency in purification is generally low, resulting in high production costs of biopharmaceuticals. However, BIASep has developed CIM® Monoliths (CIM Convective Interaction Media®), which ensure more efficient purification, compared with competitors’ purification resins.

SDK has judged that it is best to enter into a tie-up with BIASep to realize a participation in the purification resin market.

Through the partnership arrangement with BIASep, SDK will acquire know-how concerning development, production, quality control, and marketing of purification resins.

Furthermore, SDK will aim to strengthen business relations with producers of biopharmaceuticals, thereby expanding its separation/refining business.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Uncovering Cancer’s ‘Invisibility Cloak’
Researchers discover cancer cell mechanism to become invisible to the body's immune system.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!